This is the fifth of a seven-essay collection measuring the distance between the decades of my life and the moment we are in now.
The 2010s — Looking Down
If you want to understand the 2010s, look at any photograph of a crowd from that decade. A concert, a parade, a ballgame. Almost everyone is looking down at a glowing rectangle, faces lit from below like children telling ghost stories around a campfire.
That is the portrait of the decade. We held the whole world in our palms, and we stopped looking up.

I was in my forties then. I had been blessed with early professional success and financial comfort in my thirties, more than I ever needed, and had been handed leadership earlier than most. So I entered the decade from a place of stability, wondering what I owed the community that had given me more than I deserved.
That question changed the way I measured time. Somewhere in my mid-thirties I stopped thinking in years and began thinking in fifty- and hundred-year spans. What would my city look like when my future grandchildren were my age? What could we plant now that someone else would sit in the shade of?
Seen from that distance, the 2010s look less like a decade than a planting season. Nearly everything that defines the present, from the chatbot on your phone to the gene therapy in a Philadelphia hospital to the fury of our politics, went into the ground between 2010 and 2019. Most of it was planted quietly, while we argued about something louder. And I should confess at the outset that I was both a gardener and one of the people staring at his phone.
The Soil
Every seed needs soil, and the soil of the 2010s was broken trust.
The decade opened in the rubble of 2008. Millions of Americans lost homes and jobs while the institutions that caused the crash were rescued. I had spent the 2000s representing structured finance companies, so I watched that collapse as an insider. What broke was not only balance sheets, but the quiet assumption that the people in charge knew what they were doing and were, broadly, on our side.
READ: The Review by Ajay Raju | Fifty-six trips around the sun — Part 4 of a 7-Essay collection (November 9, 2026)
The anger arrived in the streets before it arrived on our screens. In September 2011, a few hundred protesters pitched tents in Zuccotti Park, a small plaza a few blocks from Wall Street. Within weeks, Occupy encampments had spread to hundreds of cities. Here in Philadelphia, protesters camped on Dilworth Plaza in the shadow of City Hall from October until police cleared them at the end of November.
Occupy had no leaders, no list of demands, and no plan for winning anything, and most of the camps were gone by winter. It was easy to dismiss, and many of us did. But it left behind a phrase that outlived every tent: “We are the 99 percent.” Before Occupy, Americans argued about deficits. After it, they argued about inequality, and they still do.
Occupy had an older sibling on the right. Two years earlier, the Tea Party had grown out of the same fury at bailouts, aimed at Washington rather than Wall Street. One movement blamed the bankers, the other blamed the government that saved them. Both were saying the same thing: the system was rigged, and not for us. A decade later, their children would meet again in the politics of 2016, one wearing a Bernie button and the other a red hat.
Almost everything the 2010s built was an answer to that broken trust. Social media promised we could trust each other instead of the gatekeepers. Bitcoin promised money that needed no bank. Populists promised to tear down the establishment that had failed us. Some of those answers healed the wound. Some deepened it. Sorting out which is which has become the work of the 2020s.
Envy
Instagram launched in 2010. By the end of the decade, nearly every American teenager carried a smartphone. Each app learned, one engagement metric at a time, to do the same thing: show you everyone else’s best moments and invite you to measure your ordinary life against them.
This was the great cruelty of the era. The millennials, and then Gen Z, had been sheltered from hard competition as children. Then they walked into the harshest competition ever invented, scored in likes and followers, in public, around the clock, with a permanent record.
We built a machine to bring people together, and it did, but it also proved very good at making them feel alone. Both things are true, and the second does not cancel the first. It took us most of a decade to admit the cost, and 2026 is the year the admission moved from the op-ed page to the courtroom. In 2024, the U.S. Surgeon General called for warning labels on social media, the way we once labeled cigarettes. In March of this year, a Los Angeles jury found Meta and YouTube negligent in the design of their platforms and liable for harming a young woman who had started using them as a child. It was the first verdict of its kind, and thousands of similar cases stand behind it.
The lawyers did not argue about what anyone posted. Instead, they argued about the architecture: the infinite scroll, the autoplay, the beauty filter. A day earlier, a New Mexico jury had ordered Meta to pay $375 million under the state’s consumer protection law. The comparison to tobacco is no longer a metaphor, but a litigation strategy.
Across America, schools are pulling phones out of classrooms, and parents who grew up in that 2010s crowd are now deciding when to hand a phone to their own kids.
The reckoning is arriving just as the next version of the machine shows up. In the 2010s, an algorithm chose what we saw. Today, an AI can talk back, flatter us, and keep us company at two in the morning. The same engagement logic that taught a feed to keep us scrolling can teach a companion to keep us talking. It took fifteen years and a jury to name the first design flaw. I hope we will not need fifteen more to name the second.
The Quiet Paper
While we were scrolling, something enormous was happening in computer science, and almost no one outside the field noticed.
In 2012, a small team at the University of Toronto used the same graphics chips that powered video games to win an image-recognition contest by a stunning margin. Deep learning took off. In 2016, a program called AlphaGo beat Lee Sedol, one of the world’s best players of the ancient game of Go, a milestone experts had said was years away. One of its moves was so strange that commentators first assumed it was a mistake. It was the move of something that did not think like us.
Then, in 2017, a group of Google researchers published a paper with an oddly casual title: “Attention Is All You Need.” It described a new way of building AI called the transformer. That’s the “T” in ChatGPT. Every chatbot you have used grew from that one short paper.
The 2010s were when AI stopped being science fiction and became an engineering problem. Less than a decade later, these systems write code, draft contracts, read scans, and act on our behalf. In my own world of life sciences, they help scientists sift through molecules and forgotten drugs faster than any human lab could. The race to build them has become a contest between nations, fought over chips, power plants, and data centers. And the chips at the center of that contest are descendants of the ones those Toronto researchers borrowed from gamers.
This year the quiet paper finally became loud. In the midterm campaign just ended, the data center turned out to be a kitchen-table issue. Voters in both parties connected the AI boom to their rising electric bills, to the hum of server farms, to water drawn from their rivers. Gallup found seven in ten Americans opposed new AI data centers in their own communities. Here in the mid-Atlantic, where our regional grid’s capacity auctions have sent bills climbing, candidates who had never said the word “transformer” found themselves asked to take a side on one. A technology born in a research lab nine years ago is now on the ballot, even where its name is not.
Notice, too, who reaped the harvest. The transformer was invented at Google, but the product that made the world pay attention came from a startup, and all eight of the paper’s authors eventually left Google, most to build companies of their own. The seed was planted in one garden and bore fruit in others.
READ: The Review by Ajay Raju | Fifty-six trips around the sun: Part 3 of a 7-Essay collection (November 2, 2026)
What strikes me most is how quiet the beginning was. The big shifts rarely announce themselves. They hide in plain sight while we argue about something louder, until one day they arrive in the mailbox with the electric bill.
The Long Game
If the AI race is now mainly a contest between two nations, the other nation entered the decade with a plan, and we did not.
In November 2012, the same month Americans re-elected Barack Obama, Xi Jinping became the head of China’s Communist Party. For thirty years, Washington had told itself a comfortable story: bring China into the world economy, and prosperity would make it more like us. Xi spent the 2010s proving that story wrong.
He moved quickly and thought in decades. In 2013 he launched the Belt and Road Initiative, lending hundreds of billions of dollars to build ports, railways, and power plants across Asia, Africa, and beyond. In 2015 came Made in China 2025, a blueprint to lead the world in robotics, electric vehicles, semiconductors, and biotechnology. In 2018 he had term limits on his own presidency abolished. That same year, America answered with tariffs, and a trade war began that has never really ended. By decade’s end, Hong Kong was in the streets, Huawei was on a blacklist, and both parties in Washington had stopped calling China a partner.
Xi was planting for a 100-year harvest. The Chinese seeds have sprouted in places Americans did not expect. China now dominates electric vehicles, solar panels, batteries, and the rare earths that power them. In my own field, Chinese biotech companies have become a major source of new drug candidates licensed by Western pharmaceutical giants. Molecules discovered in Shanghai and Suzhou now fill the pipelines of companies headquartered in New Jersey and Pennsylvania. That is a competition my region cannot afford to lose, and it is the reason why we must keep our own discoveries at home.
This year the two super powers are talking more than they have in a decade. President Trump went to Beijing in May, the first visit by a sitting American president in nearly nine years. Xi came to Washington in September. The two governments extended their trade truce to January 10 and agreed to open a dialogue on artificial intelligence, which Washington billed as a conversation about superintelligence. Later this month the two leaders are due to meet again in Shenzhen, the border town Deng Xiaoping turned into a factory city. Talking is better than not talking. But a truce is not a peace, and a dialogue about superintelligence is a reminder of what both sides are racing to build.
The 2010s settled one question: China will not become America. The question for the next fifty years is whether two very different gardens can grow side by side without one setting fire to the other.
Medicine’s Future, Planted at Home
The best story of the 2010s, for me, happened a few miles from my office.
In 2012, a six-year-old girl named Emily Whitehead was dying of leukemia. Every treatment had failed. Doctors at the Children’s Hospital of Philadelphia, working with Dr. Carl June and his team at Penn, tried something no one had tried on a child. They took her own immune cells, reprogrammed them to hunt her cancer, and returned them to her body. It worked. In 2017, that approach, known as CAR-T, became the first gene therapy approved in America. Emily has now been cancer-free for more than a decade.
That same year of 2012, Jennifer Doudna and Emmanuelle Charpentier published their work on CRISPR, a tool for editing genes with a precision no one had ever had. And the mRNA science that Drew Weissman and Katalin Karikó had worked out in those same Penn labs, long dismissed by much of the scientific establishment, was being quietly developed by companies like Moderna and BioNTech, waiting for its moment.
While the headlines were about tweets and scandals, Philadelphia was helping teach the human body to heal itself. Look at where those seeds have grown. The mRNA platform carried the world through a pandemic and earned Weissman and Karikó the Nobel Prize. In 2023, America approved its first CRISPR-based therapy, for sickle cell disease. In 2025, doctors at CHOP and Penn treated a baby named KJ with a gene-editing therapy designed for him alone. And CAR-T, built to fight cancer, is now reaching into autoimmune disease. In 2024, a German team reported deep, drug-free responses in patients with lupus and myositis, and a slowing of scleroderma, after a single infusion. This June, a London trial put five of six severe lupus patients on its lower dose into remission.
The most beautiful development is that the seeds have begun to cross-pollinate. Companies are now testing CAR-T made inside the body itself, with instructions delivered by mRNA in a tiny fat bubble, no cell factory required. Two Penn discoveries from the same decade, braided into one therapy. If it works, a treatment that once required a specialized center could one day arrive as something closer to an ordinary infusion.
READ: The Review by Ajay Raju | Fifty-six trips around the sun: Part 2 of a 7-Essay collection (October 26, 2026)
But a seed is not a harvest until it reaches the people who need it. That first CRISPR cure for sickle cell carries a list price above two million dollars, for a disease that falls hardest on Black Americans and on families in Africa and India who will never see that bill paid. CAR-T still depends on specialized centers that many patients cannot reach. The science of the 2010s proved we can cure. The work of the 2020s is proving we can cure more than the fortunate few.
And a harvest can be neglected, too. In August 2025, the federal health department canceled about $500 million in mRNA vaccine projects, the very platform our city gave the world. Early this year, some of the secretary’s handpicked advisers prepared to stop recommending the mRNA COVID shots, then shelved the plan as Republicans warned that vaccine fights could cost them in the midterms. Science is supposed to move on evidence, not on the election calendar. When it moves on either, the soil of trust thins a little more.
The Other Prescription
There is a second medical story from the 2010s, and it also happened a few miles from my office, in the other direction.
While Penn was teaching the body to heal itself, Kensington was becoming the largest open-air drug market on the East Coast. In 2017, more than 1,200 Philadelphians died of overdoses, more than three times the number killed by homicide that year. Across America, overdose deaths nearly doubled over the decade, from about 38,000 in 2010 to more than 70,000 in 2019.
The epidemic did not begin with a drug dealer. It began with a prescription. Purdue Pharma sold OxyContin to doctors as a painkiller with little risk of addiction, saw an affiliate plead guilty in 2007 to misleading the public about that risk, and kept selling. When the pill was reformulated in 2010 to make it harder to abuse, many people already dependent on it turned to cheaper heroin. Then, around 2013, fentanyl flooded the supply, a synthetic opioid so potent that a few grains can kill. Three waves in one decade: the pill, the needle, the poison.
Here was the betrayal of 2008 written on a pill bottle. The doctor, the pharmacist, the regulator, the respected family name on the museum wall: every institution that was supposed to know better told Americans the medicine was safe. As an art collector, I watched the Sackler name come down from gallery walls, at the Louvre in 2019 and later at the Met. A name carved into marble, it turns out, is no sturdier than the trust behind it.
I invest in this industry. I believe, without apology, that medicine is the greatest engine of human progress we have built. The same decade that gave Philadelphia CAR-T gave it Kensington. An industry that can save a dying child can also, when it chases profit without conscience, hollow out a neighborhood. Trust is the soil our cures grow in, and the opioid makers poisoned it. Some of the suspicion of medicine that shadows the 2020s still draws from that well.
There is a hopeful turn. After peaking at nearly 108,000 in 2022, national overdose deaths have fallen for three straight years, to about 70,000 in 2025, back to where they were before the pandemic. The latest federal estimates put the toll for the twelve months ending in May near 66,500. Here at home, preliminary state figures put Philadelphia’s 2025 overdose deaths at 921, still a terrible number, but far below the worst years.
And on May 1 of this year, Purdue Pharma ceased to exist. Under a $7.4 billion bankruptcy plan, its operations passed to Knoa Pharma, a new company owned by a nonprofit foundation that will sell overdose-reversal and addiction medicines at or below cost. There is a poetic justice in that, though an incomplete one: Knoa still sells OxyContin, barred from promoting it and watched by an independent monitor. The maker of the poison has been reborn mostly as a maker of antidotes. Yet many victims found the payout process cruel in its own way, with roughly four in ten individual claims rejected.
Kensington is still there. The city has swept its streets again and again, and the drug supply keeps mutating faster than the policy. Xylazine, the veterinary sedative that leaves wounds that will not heal, is now being joined, and in places replaced, by medetomidine, another animal tranquilizer that naloxone cannot reverse. Money can settle a lawsuit, but cannot settle a debt of trust.
New Kind of Money
The 2010s also produced a very different answer to the question 2008 had left hanging: who can you trust with your money?
The answer came from a pseudonymous programmer. Bitcoin was born in the wreckage of the crash, a currency for people who no longer trusted the banks. I got into it during the decade, when most serious people laughed at it. Today it sits in ordinary retirement accounts through funds approved by the same regulators who once dismissed it. That respectability has a price. This autumn Bitcoin trades around $74,000, nearly a third below where it stood a year ago, and the selling has been led by the very exchange-traded funds that brought it into the mainstream. The protest against Wall Street now moves with Wall Street’s moods. The argument over what it will become is far from settled.
Hope, Then the Sorting
America entered the 2010s with its first Black president in the White House, elected in the shadow of the crash. Barack Obama was, for someone like me who arrived in 1983, a living argument that the American story was still open to new authors. He was also the decade’s first answer to broken trust: a promise of hope delivered to people who had just watched the system fail them.
He was something else, too, though few saw it at the time. His campaigns were the first to master the new machine, organizing volunteers online, raising money in small amounts from millions, and by 2012 mining data to find every persuadable voter. Back then it was celebrated as democracy renewed. Four years later, a candidate who ran against nearly everything he represented used the same tools even more effectively. That is the pattern of the decade in miniature. The technology did not choose sides, but amplified whoever used it best.
Donald Trump, the politician, was a creation of the 2010s too. He found his political voice in 2011 questioning where Obama was born, and soon learned on Twitter that the feed rewards provocation above everything else. In 2016 he rode the anger of 2008, a deep distrust of every establishment, and a medium built for outrage all the way to the White House, then governed through that medium, one post at a time. His supporters saw a man finally saying what the gatekeepers would not. His critics saw the machine for envy rebuilt as a machine for grievance. Both readings grew from the same soil. Today he is back in the White House, and the politics of the 2020s still runs on the operating system written in the 2010s.
Obama and Trump, so different in nearly every way, were the decade’s two great answers to broken trust. One promised to restore it. The other promised to tear down the house that had lost it. Somewhere between six and nine million Americans voted for Obama and then for Trump, and that fact alone should humble anyone who claims to fully understand this country.
A week ago, that same restless electorate delivered another verdict. On November 3, voters handed Democrats control of both the House and the Senate. They flipped seven Republican Senate seats, in Maine, North Carolina, South Carolina, Ohio, Iowa, Kansas, and Texas. Kansas had not elected a Democratic senator since 1932, Texas not since 1988. As I write, Alaska and Mississippi are still counting. Hakeem Jeffries is in line to become the first Black Speaker of the House. The president accepted the results, and the markets exhaled.
The exit polls read like a household budget. Nearly nine in ten voters called the cost of living a crucial or major factor in their vote, and nine in ten said the same of corruption. Tariffs that lifted prices, a war with Iran launched in February that lifted gasoline, and in more than a few districts the data center down the road all weighed on the party in power. Republicans will argue, with some justice, that midterms punish nearly every president, that a war fought to keep a nuclear weapon out of Tehran will be judged over years rather than months, and that their losses are recoverable. Democrats will soon learn that winning on affordability is easier than delivering it.
From fifty years out, the result fits a pattern. Obama won on hope in 2008, and his party lost the House two years later. Trump won in 2016 and lost the House in 2018. He won again in 2024 promising to bring prices down, and now his party has lost both chambers. Each time, voters who no longer trust the institutions hire someone to fix them, then fire that person’s party when the fix does not arrive fast enough. That is not a realignment, but the tremor of a wound that never closed. Some of those six to nine million Obama-Trump voters, surely, have just swung back again, and they will not stay put for anyone who mistakes their vote for their loyalty.
Around the world, the earth kept shaking. The Arab Spring, when young people with smartphones helped topple governments and then watched, in too many places, as things got worse. Brexit in 2016. A wave of populist politics across the globe, including in America and India.
At home, the same phone that isolated us also became a megaphone. In 2014, after a police officer shot and killed Michael Brown in Ferguson, Missouri, livestreams and hashtags carried the protests across the country, and Black Lives Matter grew from a hashtag into a national movement. In 2017, two words, #MeToo, did in months what decades of lawsuits had not, toppling powerful men across Hollywood, media, and business. In 2018, after a gunman killed seventeen people at a high school in Parkland, Florida, students organized March for Our Lives, one of the largest youth protests in American history, largely from their phones.
Each of these movements changed the national conversation. Each also became another front in the sorting, cheered by one team and resented by the other, until a hashtag could tell you which side someone was on.
People will argue about the causes of that sorting forever, and I distrust anyone who offers just one. Polarization in America was rising long before the iPhone, carried by talk radio and cable news, and some research finds it grew fastest among older Americans, the people least likely to be on social media. So the phone did not invent our anger. But the anger from 2008 never healed, and social media turned it into fuel. Every outrage could spread in minutes, and every group could find its own facts. The tools that promised to connect us also helped sort us into teams.
We are still living inside that sorting. In the 2010s, the danger was a misleading headline shared a million times. Today, it is a video of a candidate saying something they never said, made in minutes by anyone with a laptop. The subtler danger may be the reverse: when anything can be faked, anything real can be denied. The 2010s taught us that technology can amplify our worst instincts. The 2020s are testing whether we learned anything from it. One small sign that we did: this month’s election, for all its fury, was counted, and the losing side accepted it. In a decade of broken trust, a peaceful handover of power is itself a kind of harvest.
The Long Way Here
Of all the sortings of the 2010s, the one I felt most personally was the argument over who gets to become an American.
When I arrived in 1983, immigration was mostly a quiet bargain. Come, work hard, and the country would make room for you. The bargain was never as generous as we remember, but it was broadly accepted by both parties. Ronald Reagan signed an amnesty for nearly three million people three years after I landed. By the end of the 2010s, that bargain was gone, and no one has yet written a new one.
The decade began with a gesture of welcome. In 2012, President Obama created DACA, which let young people brought here illegally as children work and study without fear of deportation. Hundreds of thousands of “Dreamers” signed up. They were, in a sense, my generation of immigrants with the paperwork missing: kids who had pledged allegiance in American classrooms and knew no other home. Congress never gave them a permanent answer. They are still waiting.
Then the world started moving. In 2014, tens of thousands of unaccompanied children from Central America arrived at our southern border, fleeing gangs and poverty. In 2015, the Syrian civil war pushed more than a million refugees and migrants into Europe. That September, a photograph of a small Syrian boy named Alan Kurdi, drowned and face down on a Turkish beach, went around the world in hours. Germany’s Angela Merkel opened her country’s doors and told Germans they could manage it. Many Europeans decided they could not. A year later, the fear of open borders helped carry Brexit to victory.
In America, a candidate opened his 2015 campaign by talking about Mexican immigrants and promising a wall. Within his first week in office, he banned travel from several Muslim-majority countries. In 2018, his zero-tolerance policy separated thousands of children from their parents at the border, and the images of children in holding facilities became the decade’s Alan Kurdi moment for America. Refugee admissions, which had stood at 85,000 in Obama’s last year, were cut to 18,000 by decade’s end, the lowest since the modern program began. His supporters saw a government finally enforcing laws that both parties had ignored. His critics saw cruelty as policy. Both were reacting to a system that had failed for thirty years to decide what it wanted.
For Indian immigrants, the decade carried its own quiet paradox. Indians became one of the largest and most successful immigrant groups in America, running some of its biggest companies and staffing its hospitals and labs. Yet an Indian engineer who applied for a green card in the 2010s may wait decades for it, because of per-country caps written before most of today’s immigrants were born. Last year a new $100,000 fee on H-1B visas made the front door narrower still. We wanted the talent, but we never quite decided we wanted the people.
The seeds of that confusion are now fully grown. Illegal border crossings have fallen sharply, and the administration’s mass deportation campaign has made masked federal agents a familiar sight in American cities, including our own region. Last week’s exit polls captured the country’s divided mind. Most voters disapproved of how ICE is doing its job, yet in NBC’s poll voters still narrowly trusted Republicans over Democrats on immigration. Americans, it seems, want a secure border and are uneasy with what securing it looks like on their own street.
I agree with most Americans on this issue. I believe a nation has every right to decide who enters, and a law no one enforces teaches contempt for every other law. I also know what it means to arrive in a country with a few suitcases and a great deal of hope.
Many Hands
The foundation of my working life was poured in the late 2000s, after the crash pushed me to diversify. The 2010s were when we built on it, broadened it, and scaled it. And I say “we” deliberately.
READ: The Review by Ajay Raju | Fifty-six trips around the sun: First of 7 essays (October 19, 2026)
By then I had a large team of colleagues and close friends, and we began to build together. We launched a news outlet, The Philadelphia Citizen, just as local journalism was collapsing across the country, because a city that cannot trust its own news cannot govern itself. We started the Germination Project to grow the next generation of civic leaders, and The Ten Program alongside it. We founded 215 Capital to invest in the technology and life sciences companies taking root in our region, so that the next CAR-T would not have to leave home to grow up, and we helped start and operate several of those companies ourselves. Everything I have built since has been built with many hands, and those hands are still my partners and collaborators today.
Looking Up
So what did the 2010s take from us, and what did they give?
They took a kind of patience with one another. It used to be easier to disagree with someone and still have dinner with them. The algorithms learned that anger keeps us scrolling, and we let them teach us. They took, too, hundreds of thousands of lives to a pill we were told was safe. They took the old immigrant bargain that warmly welcomed a boy from Bhopal, and the comfortable belief that a richer China would become a freer one.
They gave us the AI systems now remaking work, the gene therapies now reaching patients, the mRNA platform that would soon be tested in the hardest way imaginable. They gave a generation of young people a megaphone, and gave the 99 percent a name. They also gave us the politics we live in now. Almost none of it was fully visible while it was being planted.
For me, the decade gave something else: clarity. By its end, I knew why I existed and for whom I existed. My business, civic, and charitable ambitions stopped pulling in different directions and began pointing the same way, toward a region that could cure diseases, raise leaders, and hold on to its own talent. The fifty-year view I had reached for in my late thirties finally had a shape. And the people I was building it for finally included, first and foremost, the ones at home. Today I am a grandfather, and the question I asked in my late thirties, what my city would look like when my grandchildren were my age, is no longer an abstraction.
The Warnings
The decade did not end without warning us. It warned us twice.
In 2014, Ebola tore through Guinea, Liberia, and Sierra Leone, infecting more than 28,000 people and killing more than 11,000. That fall, a Liberian man fell ill in Dallas and died there, and two of the nurses who treated him were infected. For a few weeks, America panicked. Just up the turnpike, a nurse returning from Sierra Leone was held in a tent outside a Newark hospital, though she had no symptoms. The White House appointed an “Ebola czar,” and the outbreak was contained before it could spread here. Then we moved on.
In 2015 and 2016, it was Zika, a mosquito-borne virus that left babies in Brazil born with devastating brain damage. The World Health Organization declared a global emergency, and by summer mosquitoes were spreading the virus in a Miami neighborhood. The president asked Congress for emergency money in February. Congress, divided, argued for seven months before passing a smaller sum. Within months, in a Penn lab, Drew Weissman’s team showed that a single small dose of an mRNA vaccine could protect animals against Zika. Almost no one outside science noticed.
The lessons were all there. Viruses travel faster than politics. Preparation is cheap, and panic is expensive. And a city like ours already held one of the tools the next pandemic would require. In 2015, Bill Gates gave a talk warning that the world was not ready for the next outbreak. Millions watched it. Few acted on it.
On the last day of 2019, health officials in Wuhan, China, reported a cluster of pneumonia cases with no known cause. Almost no one in Philadelphia, other than the scientists at Penn Medicine, noticed. Like every big shift of that decade, it began quietly.
The seeds were in the ground. We were about to find out, faster than anyone imagined, what they would grow into.
Next: The 2020s — Now.


